Fig. 2
From: Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
Methods used for BRCA1/BRCA2 variant identification. The number and percentage of non-US (a/b) and US laboratories (c/d) reporting use of each method for identification of BRCA1/BRCA2 sequence variants (a/c) and large rearrangements (b/c) are noted. The percentage of laboratories reporting the use of more than one technology for variant detection was a 40%, b 38%, c 75%, and d 75%. Multiplex ligation-dependent probe amplification (MPLA); massively parallel sequencing (MPS); array comparative genomic hybridization (array CGH)
